Does low vitamin D weaken immune tolerance and raise thyroid autoantibodies in autoimmune thyroid disease?

The relationship between vitamin D status and autoimmune thyroid disease (AITD) is supported by robust clinical and mechanistic evidence. Vitamin D acts as a critical immunomodulator, and its deficiency is consistently linked to the loss of immune tolerance and the elevation of thyroid autoantibodies.

Clinical effectiveness and associations

Clinical data, including meta-analyses of randomized controlled trials (RCTs) and case-control studies, demonstrate a significant inverse correlation between serum 25(OH)D levels and thyroid autoantibody titers.

• Autoantibody reduction: A 2024 meta-analysis of 12 RCTs found that vitamin D supplementation significantly reduces thyroid peroxidase antibodies (TPOAb) and thyroglobulin antibodies (TgAb) in patients with Hashimoto’s thyroiditis.
• Correlation metrics: Observational data show a strong negative correlation (e.g., r = -0.610) between 25(OH)D and anti-TPO levels, indicating that as vitamin D levels drop, autoantibody levels typically rise.
• Prevalence: Patients with AITD are significantly more likely to be vitamin D deficient compared to healthy controls, with the severity of deficiency often tracking with the severity of the autoimmune response.

Mechanistic explanations

Vitamin D maintains immune tolerance through the Vitamin D Receptor (VDR) pathway, which is expressed across diverse immune cell populations.

• T-cell modulation: The active form of vitamin D, 1,25(OH)₂D₃, promotes the differentiation of FoxP3+ regulatory T cells (Tregs) while suppressing pro-inflammatory Th17 and Th1 cells. This shift restores the balance between tolerance and inflammation.
• B-cell suppression: Vitamin D directly inhibits B-cell proliferation and their differentiation into plasma cells, which reduces the overall production of immunoglobulins and specific thyroid-targeted autoantibodies.
• Dendritic cell function: It induces a "tolerogenic" phenotype in dendritic cells, reducing their ability to present antigens and activate self-reactive T cells.

Bottom line

Low vitamin D status weakens immune tolerance by impairing regulatory T-cell function and enhancing pro-inflammatory pathways. This deficiency is strongly associated with higher levels of thyroid autoantibodies in AITD, and correcting deficiency can lead to a measurable reduction in these antibodies.